Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CSPC Pharmaceutical Group Limited Earnings Release 2005

Jun 9, 2005

49680_rns_2005-06-09_75adfb6b-e35c-447a-8c12-c5ca4626731a.htm

Earnings Release

Open in viewer

Opens in your device viewer

Listed Company Information

Listed Company Information
CHINA PHARMA<01093> - Results Announcement

China Pharmaceutical Group Limited announced on 09/06/2005:
(stock code: 01093 )
Year end date: 31/12/2005
Currency: HKD
Auditors' Report: N/A
Interim/Quarterly report reviewed by: Both Audit Committee and Auditors

(Unaudited )
(Unaudited ) Last
Current Corresponding
Period Period
from 01/01/2005 from 01/01/2004
to 31/03/2005 to 31/03/2004
Note ('000 ) ('000 )
Turnover : 724,242 580,597
Profit/(Loss) from Operations : 60,698 102,033
Finance cost : (10,992) (4,197)
Share of Profit/(Loss) of
Associates : N/A N/A
Share of Profit/(Loss) of
Jointly Controlled Entities : 88 1,268
Profit/(Loss) after Tax & MI : 47,298 84,745
% Change over Last Period : -44 %
EPS/(LPS)-Basic (in dollars) : 0.0308 0.0551
-Diluted (in dollars) : N/A N/A
Extraordinary (ETD) Gain/(Loss) : N/A N/A
Profit/(Loss) after ETD Items : 47,298 84,745
1st Quarter Dividend : Nil Nil
per Share
(Specify if with other : N/A N/A
options)

B/C Dates for
1st Quarter Dividend : N/A
Payable Date : N/A
B/C Dates for (-)
General Meeting : N/A
Other Distribution for : N/A
Current Period

B/C Dates for Other
Distribution : N/A

Remarks:


The calculation of the basic earnings per share for the three
months ended March 31, 2005 is based on the profit attributable to
shareholders of the Company of HK$47,298,000 (2004: HK$84,745,000) and 1,
538,124,661 shares (2004: 1,538,124,661 shares) in issue during the
period.

No diluted earnings per share is presented for the three months
ended March 31, 2005 as there was no potential ordinary shares in issue
during the period.